Literature DB >> 10565904

Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.

V O Thomsen1, U B Dragsted, J Bauer, K Fuursted, J Lundgren.   

Abstract

In the present study we compared the clinical presentations of patients with a clinical diagnosis of AIDS and disseminated Mycobacterium genavense infection (n = 12) with those of patients with AIDS and disseminated M. avium complex (MAC) infection (n = 24). Abdominal pain was seen more frequently in the group of patients infected with M. genavense than in patients infected with MAC (P = 0. 003). Analysis of microbiological data revealed that stool specimens from patients infected with M. genavense were more often smear positive than stool specimens from patients infected with MAC (P = 0. 00002). However, M. genavense could be cultured on solid media from only 15.4% of the stool specimens, whereas MAC could be cultured from 71.4% of the specimens. Bone marrow and liver biopsy specimens yielded growth of M. genavense within a reasonably short time, allowing species identification by DNA technology. Microbiological data clearly demonstrated the importance of acidic liquid medium for primary culture, the avoidance of pretreatment and the use of additives in culture, and the necessity for prolonged incubation if M. genavense is suspected. Susceptibility testing showed that M. genavense is sensitive to rifamycins, fluoroquinolones, and macrolides, whereas it is resistant to isoniazid. Susceptibility to ethambutol and clofazimine could not be evaluated. The mean survival times of patients in the two groups were similar.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565904      PMCID: PMC85841     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction.

Authors:  J M Dumonceau; A Van Gossum; M Adler; J P Van Vooren; P A Fonteyne; H De Beenhouwer; F Portaels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

2.  Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients.

Authors:  S H Siddiqi; A Laszlo; W R Butler; J O Kilburn
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

3.  Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures.

Authors:  L Realini; P Van Der Stuyft; K De Ridder; B Hirschel; F Portaels
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Mycobacterium genavense. Autopsy findings in three patients.

Authors:  H Maschek; A Georgii; R E Schmidt; P Kirschner; E C Böttger
Journal:  Am J Clin Pathol       Date:  1994-01       Impact factor: 2.493

5.  Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey.

Authors:  F Portaels; L Realini; L Bauwens; B Hirschel; W M Meyers; W de Meurichy
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.

Authors:  M Pechère; M Opravil; A Wald; J P Chave; M Bessesen; A Sievers; R Hein; J von Overbeck; R A Clark; E Tortoli
Journal:  Arch Intern Med       Date:  1995-02-27

7.  Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy.

Authors:  M T Bessesen; J Shlay; B Stone-Venohr; D L Cohn; R R Reves
Journal:  AIDS       Date:  1993-10       Impact factor: 4.177

8.  Mycobacterium genavense sp. nov.

Authors:  E C Böttger; B Hirschel; M B Coyle
Journal:  Int J Syst Bacteriol       Date:  1993-10

Review 9.  Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature.

Authors:  E Tortoli; F Brunello; A E Cagni; D Colombrita; D Dionisio; L Grisendi; V Manfrin; M Moroni; C Passerini Tosi; G Pinsi; C Scarparo; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

10.  Disseminated Mycobacterium genavense infection in Canadian AIDS patients.

Authors:  S D Shafran; G D Taylor; J A Talbot
Journal:  Tuber Lung Dis       Date:  1995-04
View more
  14 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Mesenterial involvement of Mycobacterium genavense infection: hard to find, hard to treat.

Authors:  Nasstasja Wassilew; Laura Ciaffi; Alexandra Calmy
Journal:  BMJ Case Rep       Date:  2015-05-14

Review 3.  Nontuberculous mycobacteria infection in solid organ transplant recipients.

Authors:  C Piersimoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-07       Impact factor: 3.267

4.  Persistence of nontuberculous mycobacteria in a drinking water system after addition of filtration treatment.

Authors:  Elizabeth D Hilborn; Terry C Covert; Mitchell A Yakrus; Stephanie I Harris; Sandra F Donnelly; Eugene W Rice; Sean Toney; Stephanie A Bailey; Gerard N Stelma
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

5.  To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era.

Authors:  Maura Manion; Niamh Lynn; Luxin Pei; Dima A Hammoud; Elizabeth Laidlaw; Gregg Roby; Dorinda Metzger; Yolanda Mejia; Andrea Lisco; Adrian Zelazny; Steve Holland; Marie-Louise Vachon; Matthew Scherer; Colm Bergin; Irini Sereti
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 9.079

Review 6.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

7.  Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2.

Authors:  François Trueba; Michel Fabre; Patrick Saint-Blancard
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Pulmonary Kaposi sarcoma and disseminated Mycobacterium genavense infection in an HIV-infected patient.

Authors:  Cindy Tribuna; Cristina Ângela; Isabel Eira; Alexandre Carvalho
Journal:  BMJ Case Rep       Date:  2015-10-08

9.  Infection with Mycobacterium genavense in a patient with systemic lupus erythematosus.

Authors:  Johan Lorenzen; Dirk Meyer-Olson; Marion Haubitz; Torsten Witte; Franz Bange; Reinhold Schmidt; Matthias Stoll
Journal:  Clin Rheumatol       Date:  2009-02-28       Impact factor: 2.980

10.  Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.

Authors:  Blandine Rammaert; Louis-Jean Couderc; Elisabeth Rivaud; Patrick Honderlick; David Zucman; Marie-France Mamzer; Pierre Cahen; Emmanuel Bille; Marc Lecuit; Olivier Lortholary; Emilie Catherinot
Journal:  BMC Infect Dis       Date:  2011-11-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.